253 related articles for article (PubMed ID: 20936300)
1. Early atrophy of pallidum and accumbens nucleus in Huntington's disease.
van den Bogaard SJ; Dumas EM; Acharya TP; Johnson H; Langbehn DR; Scahill RI; Tabrizi SJ; van Buchem MA; van der Grond J; Roos RA;
J Neurol; 2011 Mar; 258(3):412-20. PubMed ID: 20936300
[TBL] [Abstract][Full Text] [Related]
2. Shape analysis of subcortical nuclei in Huntington's disease, global versus local atrophy--results from the TRACK-HD study.
van den Bogaard SJ; Dumas EM; Ferrarini L; Milles J; van Buchem MA; van der Grond J; Roos RA
J Neurol Sci; 2011 Aug; 307(1-2):60-8. PubMed ID: 21624624
[TBL] [Abstract][Full Text] [Related]
3. Elevated brain iron is independent from atrophy in Huntington's Disease.
Dumas EM; Versluis MJ; van den Bogaard SJ; van Osch MJ; Hart EP; van Roon-Mom WM; van Buchem MA; Webb AG; van der Grond J; Roos RA;
Neuroimage; 2012 Jul; 61(3):558-64. PubMed ID: 22480728
[TBL] [Abstract][Full Text] [Related]
4. Grey matter volume loss is associated with specific clinical motor signs in Huntington's disease.
Coppen EM; Jacobs M; van den Berg-Huysmans AA; van der Grond J; Roos RAC
Parkinsonism Relat Disord; 2018 Jan; 46():56-61. PubMed ID: 29128164
[TBL] [Abstract][Full Text] [Related]
5. Basal ganglia atrophy in prodromal Huntington's disease is detectable over one year using automated segmentation.
Majid DS; Aron AR; Thompson W; Sheldon S; Hamza S; Stoffers D; Holland D; Goldstein J; Corey-Bloom J; Dale AM
Mov Disord; 2011 Dec; 26(14):2544-51. PubMed ID: 21932302
[TBL] [Abstract][Full Text] [Related]
6. Regional subcortical shape analysis in premanifest Huntington's disease.
Tang X; Ross CA; Johnson H; Paulsen JS; Younes L; Albin RL; Ratnanather JT; Miller MI
Hum Brain Mapp; 2019 Apr; 40(5):1419-1433. PubMed ID: 30376191
[TBL] [Abstract][Full Text] [Related]
7. Local synchronicity in dopamine-rich caudate nucleus influences Huntington's disease motor phenotype.
Kasper J; Eickhoff SB; Caspers S; Peter J; Dogan I; Wolf RC; Reetz K; Dukart J; Orth M
Brain; 2023 Aug; 146(8):3319-3330. PubMed ID: 36795496
[TBL] [Abstract][Full Text] [Related]
8. Multimodal imaging biomarkers in premanifest and early Huntington's disease: 30-month IMAGE-HD data.
D JF; Stout JC; Poudel G; Churchyard A; Chua P; Egan GF; Georgiou-Karistianis N
Br J Psychiatry; 2016 Jun; 208(6):571-8. PubMed ID: 26678864
[TBL] [Abstract][Full Text] [Related]
9. Altered brain iron content and deposition rate in Huntington's disease as indicated by quantitative susceptibility MRI.
Chen L; Hua J; Ross CA; Cai S; van Zijl PCM; Li X
J Neurosci Res; 2019 Apr; 97(4):467-479. PubMed ID: 30489648
[TBL] [Abstract][Full Text] [Related]
10. Distribution of grey matter atrophy in Huntington's disease patients: a combined ROI-based and voxel-based morphometric study.
Douaud G; Gaura V; Ribeiro MJ; Lethimonnier F; Maroy R; Verny C; Krystkowiak P; Damier P; Bachoud-Levi AC; Hantraye P; Remy P
Neuroimage; 2006 Oct; 32(4):1562-75. PubMed ID: 16875847
[TBL] [Abstract][Full Text] [Related]
11. Widespread subcortical grey matter degeneration in primary lateral sclerosis: a multimodal imaging study with genetic profiling.
Finegan E; Li Hi Shing S; Chipika RH; Doherty MA; Hengeveld JC; Vajda A; Donaghy C; Pender N; McLaughlin RL; Hardiman O; Bede P
Neuroimage Clin; 2019; 24():102089. PubMed ID: 31795059
[TBL] [Abstract][Full Text] [Related]
12. Clinicopathological differences between the motor onset and psychiatric onset of Huntington's disease, focusing on the nucleus accumbens.
Hirano M; Iritani S; Fujishiro H; Torii Y; Habuchi C; Sekiguchi H; Yoshida M; Ozaki N
Neuropathology; 2019 Oct; 39(5):331-341. PubMed ID: 31264738
[TBL] [Abstract][Full Text] [Related]
13. White matter integrity in premanifest and early Huntington's disease is related to caudate loss and disease progression.
Novak MJ; Seunarine KK; Gibbard CR; Hobbs NZ; Scahill RI; Clark CA; Tabrizi SJ
Cortex; 2014 Mar; 52():98-112. PubMed ID: 24405816
[TBL] [Abstract][Full Text] [Related]
14. Increased brain tissue sodium concentration in Huntington's Disease - a sodium imaging study at 4 T.
Reetz K; Romanzetti S; Dogan I; Saß C; Werner CJ; Schiefer J; Schulz JB; Shah NJ
Neuroimage; 2012 Oct; 63(1):517-24. PubMed ID: 22796981
[TBL] [Abstract][Full Text] [Related]
15. Biological and clinical changes in premanifest and early stage Huntington's disease in the TRACK-HD study: the 12-month longitudinal analysis.
Tabrizi SJ; Scahill RI; Durr A; Roos RA; Leavitt BR; Jones R; Landwehrmeyer GB; Fox NC; Johnson H; Hicks SL; Kennard C; Craufurd D; Frost C; Langbehn DR; Reilmann R; Stout JC;
Lancet Neurol; 2011 Jan; 10(1):31-42. PubMed ID: 21130037
[TBL] [Abstract][Full Text] [Related]
16. Developmentally stable whole-brain volume reductions and developmentally sensitive caudate and putamen volume alterations in those with attention-deficit/hyperactivity disorder and their unaffected siblings.
Greven CU; Bralten J; Mennes M; O'Dwyer L; van Hulzen KJ; Rommelse N; Schweren LJ; Hoekstra PJ; Hartman CA; Heslenfeld D; Oosterlaan J; Faraone SV; Franke B; Zwiers MP; Arias-Vasquez A; Buitelaar JK
JAMA Psychiatry; 2015 May; 72(5):490-9. PubMed ID: 25785435
[TBL] [Abstract][Full Text] [Related]
17. Progression of structural neuropathology in preclinical Huntington's disease: a tensor based morphometry study.
Kipps CM; Duggins AJ; Mahant N; Gomes L; Ashburner J; McCusker EA
J Neurol Neurosurg Psychiatry; 2005 May; 76(5):650-5. PubMed ID: 15834021
[TBL] [Abstract][Full Text] [Related]
18. The progression of regional atrophy in premanifest and early Huntington's disease: a longitudinal voxel-based morphometry study.
Hobbs NZ; Henley SM; Ridgway GR; Wild EJ; Barker RA; Scahill RI; Barnes J; Fox NC; Tabrizi SJ
J Neurol Neurosurg Psychiatry; 2010 Jul; 81(7):756-63. PubMed ID: 19955112
[TBL] [Abstract][Full Text] [Related]
19. Early grey matter changes in structural covariance networks in Huntington's disease.
Coppen EM; van der Grond J; Hafkemeijer A; Rombouts SA; Roos RA
Neuroimage Clin; 2016; 12():806-814. PubMed ID: 27830113
[TBL] [Abstract][Full Text] [Related]
20. White and Gray Matter Abnormalities in Manifest Huntington's Disease: Cross-Sectional and Longitudinal Analysis.
Sweidan W; Bao F; Bozorgzad NS; George E
J Neuroimaging; 2020 May; 30(3):351-358. PubMed ID: 32128927
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]